NeurologyLive® Mind Moments®

150: Rethinking Parkinson’s Care: Prevention, Equity, and Access to Treatment


Listen Later

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.

In this episode, "Rethinking Parkinson’s Care: Prevention, Equity, and Access to Treatment," Michael Okun, MD, neurologist, author of The Parkinson Plan, and medical advisor for the Parkinson’s Foundation, discusses the urgent need for global access to levodopa, the gold-standard treatment for Parkinson disease. He outlines the consequences of delayed or unavailable treatment worldwide, including worsening outcomes and unnecessary disability. Okun highlights lessons from global HIV drug distribution that can inform equitable levodopa access, emphasizing the importance of tailoring strategies to local economies and healthcare systems. Additionally, he breaks down key components of The Parkinson Plan, including prevention, research priorities, amplifying patient and caregiver voices, and rethinking care models to better address the world’s fastest growing neurodegenerative disorder. Finally, he explains how the book can serve as a resource not only for clinicians, but also for patients, families, and policymakers.


Looking for more Movement disorders discussion? Check out the NeurologyLive® Movement disorders clinical focus page.

Episode Breakdown:
  • 1:00 – Consequences of delayed or unavailable levodopa treatment for patients worldwide
  • 2:40 – How universal levodopa access could change care in low-resource settings
  • 5:15 – Lessons from global HIV drug distribution for equitable levodopa delivery
  • 7:00 – Neurology News Network
  • 8:35 – Key pillars of The Parkinson Plan and rethinking Parkinson’s care models

    The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

    • EMA Approves Semaglutide as First GLP-1 RA for Cardiovascular, Stroke-Related Benefits
    • Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
    • MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne

    • Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
      ...more
      View all episodesView all episodes
      Download on the App Store

      NeurologyLive® Mind Moments®By NeurologyLive

      • 4.6
      • 4.6
      • 4.6
      • 4.6
      • 4.6

      4.6

      10 ratings


      More shows like NeurologyLive® Mind Moments®

      View all
      NEJM This Week by NEJM Group

      NEJM This Week

      321 Listeners

      Neurology® Podcast by American Academy of Neurology

      Neurology® Podcast

      302 Listeners

      Practical Neurology Podcast by BMJ Group

      Practical Neurology Podcast

      49 Listeners

      The Clark Howard Podcast by Clark Howard

      The Clark Howard Podcast

      5,457 Listeners

      JAMA Neurology Author Interviews by JAMA Network

      JAMA Neurology Author Interviews

      12 Listeners

      BMJ Best Practice Podcast by BMJ Group

      BMJ Best Practice Podcast

      21 Listeners

      Neurology Today in 5 by American Academy of Neurology

      Neurology Today in 5

      25 Listeners

      Neurology Minute by American Academy of Neurology

      Neurology Minute

      133 Listeners

      Dateline NBC by NBC News

      Dateline NBC

      47,622 Listeners

      The Ezra Klein Show by New York Times Opinion

      The Ezra Klein Show

      16,096 Listeners

      Movers and Shakers: a podcast about life with Parkinson's by Podot

      Movers and Shakers: a podcast about life with Parkinson's

      106 Listeners

      Continuum Audio by American Academy of Neurology

      Continuum Audio

      80 Listeners

      Chanticleer by Australian Financial Review

      Chanticleer

      21 Listeners

      The Top Line by Fierce Life Sciences

      The Top Line

      13 Listeners

      The Economics Show by Financial Times

      The Economics Show

      140 Listeners